Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …

Feature
biogen_austria_238

Biogen’s Spinraza to go before NICE

January 22, 2018
Sales and Marketing Biogen, Spinraza, biotech, drugs, pharma, pharmaceutical

Biogen received marketing approval from the European Commission for Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA), in May …

News
shutterstock_273326141

Abcam acquires rights to over 700 Roche products in new licensing deal

January 22, 2018
Sales and Marketing Abcam, Roche, partnership, pharma

Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …

News
facilities_lg06

Court fines Dr Reddy’s for improperly packaging products

January 22, 2018
Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …

News
epilim

20,000 left disabled in UK due to sodium valproate use during pregnancy

January 22, 2018
Medical Communications, Sales and Marketing Epilim, Sanofi, Sodium valproate, UK, pharma

Liberal Democrat MP Norman Lamb has drawn attention to what he has called an “extraordinary scandal” in which an estimated …

News
sanofi_new_paris_hq

Sanofi finally seals big deal with $11.6bn for Bioverativ

January 22, 2018
Sales and Marketing Sanofi, biotech, bioverativ, drugs, pharma, pharmaceutical

Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …

News
astrazeneca_sign_sky

AstraZeneca scores double approvals in Japan for asthma and ovarian cancer

January 19, 2018
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Fasenra, Japan, asthma, lynparza, ovarian cancer, pharma

AstraZeneca has unveiled a double dose of approvals awarded to its medicines in Japan: Fasenra (benralizumab) has been given authorisation …

News
sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018
Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …

News
pfizer-building-logo1web

Pfizer’s Xalkori sees rejection at the hands of NICE in lung cancer

January 19, 2018
Medical Communications, Sales and Marketing Cancer, NCIE, NSCLC, Pfizer, UK, Xalkori, lung cancer, pharma

UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the …

News
gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018
Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …

News
astrazeneca-sign

AstraZeneca expands drug discovery collaboration with X-Chem

January 18, 2018
Research and Development, Sales and Marketing AstraZeneca, X-Chem, pharma

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …

News
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

Feature
darzalex

NICE meets Janssen halfway over Darzalex

January 18, 2018
Medical Communications, Sales and Marketing J&J, JJ, Janssen, biotech, darzalex, drugs, pharma, pharmaceutical

NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy …

News
pregnancy_credit_needed

Evidence mounts yet again against efficacy of common morning sickness pill

January 18, 2018
Research and Development Diclegis, morning sickness, pharma

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine  (Diclegis, Diclectin), as new study data reveals …

News
blood-20745_960_720

Research calls for BRCA testing in all women

January 18, 2018
Medical Communications, Research and Development BRCA, biotech, drugs, pharma, pharmaceutical

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026